Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 561-566

  Khanna, Geetika ^a,c   O'Dorisio, M Sue ^a   Menda, Yusuf ^a   Glasier, Charles ^b   DeYoung, Barry ^a   Smith, Brian J ^a   Graham, Michael ^a   Juweid, Malik ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Brain tumors; Medulloblastoma; Octreotide; Somatostatin receptor imaging; Surveillance

Indexed keywords

GADOLINIUM; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN SCINTIANGIOGRAPHY; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; EPENDYMOMA; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INFANT; MALE; MEDULLOBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PINEAL BODY TUMOR; POSTOPERATIVE CARE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR SCINTISCANNING;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RECEPTORS, SOMATOSTATIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR MARKERS, BIOLOGICAL;

EID: 38549141812     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21194     Document Type: Article

References (28)

1. Sutton LN, Cnaan A, Klatt L, et al. Postoperative surveillance imaging in children with cerebellar astrocytomas. J Neurosurg 1996;84:721-725.
2. Torres CF, Rebsamen S, Silber JH, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med 1994;330:892-895.
3. Korones DN, Butterfield R, Meyers SP, et al. The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children. J Neurooncol 2001;53:33-38.
4. Ashdown BC, Boyko OB, Uglietta JP, et al. Postradiation cerebellar necrosis mimicking tumor: MR appearance. J Comput Assist Tomogr 1993;17:124-126.
5. Langleben DD, Segall GM, PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 2000;41:1861-1867.
6. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901-909.
7. Tzika AA, Astrakas LG, Zarifi MK, et al. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer 2004;100:1246-1256.
8. Hein PA, Eskey CJ, Dunn JF, et al. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004;25:201-209.
9. Fruhwald MC, O'Dorisio MS, Pietsch T, et al. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy. Pediatr Res 1999;45:697-708.
10. Fruhwald MC, Rickert CH, O'Dorisio MS, et al. Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging. Clin Cancer Res 2004;10:2997-3006.
11. Muller HL, Fruhwald MC, Scheubeck M, et al. A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma. J Neurooncol 1998;38:27-40.
12. Cohen J, A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
13. Gonen M, Panageas KS, Larson SM, Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology 2001;221:763-767.
14. Mendel E, Levy ML, Raffel C, et al. Surveillance imaging in children with primitive neuroectodermal tumors. Neurosurgery 1996;38:692-694. discussion 694-695.
15. Reubi JC, Kvols L, Krenning E, et al. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990;39:78-81.
16. Reubi JC, Lang W, Maurer R, et al. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 1987;47:5758-5764.
17. Rufini V, Calcagni ML, Baum RP, Imaging of neuroendocrine tumors. Semin Nucl Med 2006;36:228-247.
18. de Herder WW, Kwekkeboom DJ, Valkema R, et al. Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest 28; 2005:132-136.
19. Scheidhauer K, Hildebrandt G, Luyken C, et al. Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences. Horm Metab Res 1993;27:59-62.
20. Schmidt M, Scheidhauer K, Luyken C, et al. Somatostatin receptor imaging in intracranial tumours. Eur J Nucl Med 1998;25:675-686.
21. Lee JD, Kim DI, Lee JT, et al. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI. J Nucl Med 1995;36:537-541.
22. Ball WS, Jr., Holland SK, Perfusion imaging in the pediatric patient. Magn Reson Imaging Clin N Am 2001;9:207-230. ix
23. Chao ST, Suh JH, Raja S, et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001;96:191-197.
24. Thompson TP, Lunsford LD, Kondziolka D, Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neurosurg 1999;73:9-14.
25. Barai S, Rajkamal, Bandopadhayaya GP, et al. Thallium-201 versus Tc99m-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation. J Clin Neurosci 2005;12:27-31.
26. Guyotat J, Champier J, Jouvet A, et al. Differential expression of somatostatin receptors in ependymoma: implications for diagnosis. Int J Cancer 2001;95:144-151.
27. Stabin MG, Kooij PP, Bakker WH, et al. Radiation dosimetry for indium-111-pentetreotide. J Nucl Med 1997;38:1919-1922.
28. Kortman RD, Freeman CR, Taylor RE, Radiotherapy techniques. Walker DA, Perilongo G, Punt JAG, editors. Brain and spinal tumors of childhood. New York: Oxford University Press; 2004. 188-212.